This is a UK news story, published by Guardian.
For more UK news, you can click here:
more UK newsFor more biology news, you can click here:
more biology newsFor more news from Guardian, you can click here:
more news from GuardianOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
advanced melanoma skin cancer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest melanoma news, skin cancer news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
advanced melanomaGuardian
•
78% Informative
More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.
15 years ago , only one in 20 patients with advanced skin cancer survived for five years , with many dying within six to nine months of diagnosis.
More than 20,000 people are expected to be diagnosed with melanoma in the UK this year .
VR Score
81
Informative language
84
Neutral language
24
Article tone
informal
Language
English
Language complexity
50
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links